DIR Return Create A Forum - Home
       ---------------------------------------------------------
       Road2HardCoreIron
  HTML https://road2hardcoreiron.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: Anabolic Steroids News
       *****************************************************
       #Post#: 6233--------------------------------------------------
       Who is Zydus?
   DIR By: Road2HardCoreIron
       Date: July 29, 2025, 7:56 am
       ---------------------------------------------------------
       We rated them a 10/10.  After speaking with the rep.  They
       legit.
       We do not approve of the use of any medications without written
       permission from a licensed professional.
       Company Milestones
       Our Facilities
       Overview
       Zydus Pharmaceuticals (USA) Inc., located in Pennington, New
       Jersey, has come a long way since our first commercial launch in
       August 2005. The company currently offers more than 500 SKUs to
       the US market and is ranked the fifth largest unbranded generic
       corporation in the US based on dispensed prescriptions (IQVIA,
       NPA Audit, MAT Mar 2023). Exceptional service to both customers
       and patients who rely on its products has been a key driver for
       our success. Zydus Pharmaceuticals remains diligent in ensuring
       a quality and affordable supply of our products in the US to
       provide continuity for the patients who use our medications.
       While Zydus Pharmaceuticals has grown tremendously since it
       entered the US, we continue to look for new ways to bring value
       to the US market. We are focused on expanding our portfolio of
       complex generics, including modified release solid orals,
       transdermals, injectables, and oral suspensions to further our
       footprint in the lives of patients. To date, Zydus
       Pharmaceuticals has filed over 129 drug master files (DMFs),
       received final USFDA approval on 287 Abbreviated New Drug
       Applications (ANDAs), and has over 85 ANDAs pending approval
       with the USFDA. The company also has approximately 300
       additional products in various stages of development.
       Our Mission
       As a company, our vision, mission, and purpose exemplify our
       commitment to science and our dedication to care and nurturance.
       Vision
       Be a global life-sciences company transforming lives through
       pathbreaking discoveries.
       Mission
       To unlock new possibilities in life-sciences through quality
       healthcare solutions that impact lives.
       Purpose
       Empower people with the freedom to live healthier and more
       fulfilled lives.
       To learn more, Contact Us.
       Our Core Values
       Driven by the purpose of delivering care for the patients that
       rely on our medications and backed by the power of innovation
       and science, Zydus strives to make a meaningful difference in
       serving patients and communities. The pillars of care,
       compassion, and commitment to innovation are at the heart of our
       core.
       Zydus Lifesciences Limited
       Zydus Lifesciences Limited, the parent company of Zydus
       Pharmaceuticals, is a fully integrated, global healthcare
       provider located in Ahmedabad, India. With a legacy of over 70
       years, the company is driven by a passion for innovation and
       making a difference in the world of health and care. Zydus
       Lifesciences is India’s fourth largest pharmaceutical company
       with more than 30 manufacturing plants worldwide and business
       operations in 55 countries including, India, the US, France,
       Spain, Brazil, Mexico, and South Africa. As one of the key
       players amongst pharmaceutical manufacturing companies, Zydus
       Lifesciences has manufacturing capabilities across the entire
       pharmaceutical value chain including formulations, APIs,
       vaccines, biosimilars, complex products, animal health products,
       and wellness products. From new chemical entities to vaccines,
       biosimilars, novel biologics, and niche technologies, Zydus is
       exploring different ideas to develop differentiated medicines
       for the future. Zydus Lifescience’s ZyCoV-D vaccine was the
       world’s first plasmid DNA vaccine to be approved for human use
       and is currently approved in India as a two-dose regimen for
       adults and children aged 12 years and above. Zydus Lifesciences
       continues to innovate with an unswerving focus to address unmet
       healthcare needs and is dedicated to its mission of creating
       healthier, happier communities across the globe.
       For more information, please visit www.zyduslife.com.
       *****************************************************
       Page 1 of 1